| Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial D Khanna, CJF Lin, DE Furst, J Goldin, G Kim, M Kuwana, Y Allanore, ... The Lancet Respiratory Medicine 8 (10), 963-974, 2020 | 457 | 2020 |
| Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis S Alivernini, L MacDonald, A Elmesmari, S Finlay, B Tolusso, MR Gigante, ... Nature medicine 26 (8), 1295-1306, 2020 | 423 | 2020 |
| Post-COVID-19 global health strategies: the need for an interdisciplinary approach Aging clinical and experimental research 32 (8), 1613-1620, 2020 | 328 | 2020 |
| Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis G Peluso, A Michelutti, S Bosello, E Gremese, B Tolusso, G Ferraccioli Annals of the rheumatic diseases 70 (1), 172-175, 2011 | 246 | 2011 |
| Jean-Charles Preiser E Gremese, G Ferraccioli medicine 65, 94-100, 2013 | 237 | 2013 |
| Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: sixteen‐week results from a phase III randomized, double‐blind, placebo‐controlled … A Deodhar, D Poddubnyy, C Pacheco‐Tena, C Salvarani, ... Arthritis & rheumatology 71 (4), 599-611, 2019 | 234 | 2019 |
| Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the … F Atzeni, P Sarzi-Puttini, C Botsios, A Carletto, P Cipriani, EG Favalli, ... Autoimmunity reviews 12 (2), 225-229, 2012 | 196 | 2012 |
| MicroRNA-155—at the critical interface of innate and adaptive immunity in arthritis S Alivernini, E Gremese, C McSharry, B Tolusso, G Ferraccioli, IB McInnes, ... Frontiers in immunology 8, 1932, 2018 | 191 | 2018 |
| Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study E Gremese, F Salaffi, SL Bosello, A Ciapetti, F Bobbio-Pallavicini, ... Annals of the rheumatic diseases 72 (6), 858-862, 2013 | 174 | 2013 |
| Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis G Ferraccioli, L Bracci-Laudiero, S Alivernini, E Gremese, B Tolusso, ... Molecular medicine 16, 552-557, 2010 | 170 | 2010 |
| Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus A Bortoluzzi, CA Scire, S Bombardieri, L Caniatti, F Conti, S De Vita, ... Rheumatology 54 (5), 891-898, 2015 | 167 | 2015 |
| Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) E Gremese, B Tolusso, MR Gigante, G Ferraccioli Frontiers in immunology 5, 576, 2014 | 159 | 2014 |
| Body weight, gender and response to TNF-α blockers in axial spondyloarthritis E Gremese, S Bernardi, S Bonazza, M Nowik, G Peluso, A Massara, ... Rheumatology 53 (5), 875-881, 2014 | 151 | 2014 |
| The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk E Gremese, G Ferraccioli Autoimmunity reviews 10 (10), 582-589, 2011 | 140 | 2011 |
| Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry L Iaccarino, E Bartoloni, L Carli, F Ceccarelli, F Conti, S De Vita, ... Clinical and experimental rheumatology 33 (4), 449-456, 2015 | 137 | 2015 |
| Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression S Bosello, AL Fedele, G Peluso, E Gremese, B Tolusso, G Ferraccioli Annals of the rheumatic diseases 70 (7), 1292-1295, 2011 | 134 | 2011 |
| Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors F Iannone, E Gremese, F Atzeni, D Biasi, C Botsios, P Cipriani, C Ferri, ... The Journal of rheumatology 39 (6), 1179-1184, 2012 | 131 | 2012 |
| Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ... Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020 | 122 | 2020 |
| MicroRNA-155 influences B-cell function through PU. 1 in rheumatoid arthritis S Alivernini, M Kurowska-Stolarska, B Tolusso, R Benvenuto, ... Nature communications 7 (1), 12970, 2016 | 116 | 2016 |
| Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step‐up combination therapy (methotrexate, cyclosporin A, sulphasalazine … GF Ferraccioli, E Gremese, P Tomietto, G Favret, R Damato, E Di Poi Rheumatology 41 (8), 892-898, 2002 | 111 | 2002 |
g ferraccioliProfessor of Rheumatology, Universita' Cattolica del Sacro Cuore, Roma在 unicatt.it 的电子邮件经过验证
